trending Market Intelligence /marketintelligence/en/news-insights/trending/7XjP61xmIo-k4VEMsM9pPA2 content esgSubNav
In This List

CymaBay CEO to retire; interim named

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


CymaBay CEO to retire; interim named

Harold Van Wart is retiring as CymaBay Therapeutics Inc.'s president and CEO on April 14. He will also not stand for re-election to the board at the upcoming annual meeting of directors.

The company's CFO, Sujal Shah, will take over Wart's duties on an interim basis. Robert Wills will become executive chairman to provide continuity during the transition.